Cord Blood Derived Anti-CD19 CAR-Engineered NK Cells for B Lymphoid Malignancies

Clinical trial NCT04796675 · UNKNOWN

Trial details

NCT number: NCT04796675
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Non Hodgkin's Lymphoma

Start date: 2021-04-10
Primary completion: 2023-03-10
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.